Lawsuit Added to Federal MDL Links Actos and Bladder Cancer
A lawsuit recently added to federal multidistrict litigation (MDL) links Actos and bladder cancer in a tragic case. The complaint was originally filed in the U.S. District Court for the District of New Jersey on January 20, 2012. The case was then transferred to the Western District of Louisiana on May 7, 2012, joining a growing number of plaintiffs who… Read more »
Indiana Plaintiff Says Takeda Should Have Known Actos Could Cause Cancer
Indiana resident Dale Leiter filed one of the new Actos lawsuits in the Circuit Court of Cook County, Illinois, on May 4, 2012. Leiter seeks to hold manufacturer Takeda Pharmaceuticals and Eli Lilly & Company liable for injuries he suffered as a result of taking Actos (pioglitazone). He claims that prior to obtaining FDA approval for Actos, the defendants knew… Read more »
Takeda Whistleblower: Company Culture “Riddled With Systematic Fraud”
According to a whistleblower lawsuit, Takeda Pharmaceutical’s U.S. unit failed to accurately report adverse side effects, namely Actos heart failure, to the Food and Drug Administration (FDA). The suit was filed in Boston in 2010, but only recently unsealed and made public. The allegations in the suit were brought forward by Helen Ge, a former medical reviewer for the company,… Read more »
Actos Lawyers Claim Vague Warnings, Improper Testing of Diabetes Drug
A recent Actos cancer lawsuit filed in the Superior Court, Los Angeles County, alleges that the manufacturer of the diabetes drug, Takeda Pharmaceuticals, failed to conduct proper testing on their drug before placing it on the market. The lawsuit also alleges that Takeda offered vague warnings about the risk of Actos side effects on the product label, which did not… Read more »
FDA Rejects New Diabetes Drug That Contains Actos
A new drug developed by manufacturer Takeda Pharmaceuticals to replace the controversial diabetes drug Actos has been rejected by the FDA. The new drug combines Actos with another drug. The FDA has ordered Takeda to produce more evidence showing “how the drugs have performed in other countries where they have already been approved.” Injured plaintiffs consult an Actos lawyer Actos… Read more »
